14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 10, 2024 Buy 27 806 Mahoney David L Common Stock
Apr 10, 2024 Buy 30 000 Mahoney David L Common Stock
Apr 10, 2024 Sell 2 194 Mahoney David L Common Stock
Apr 10, 2024 Sell 27 806 Mahoney David L Common Stock
Apr 10, 2024 Sell 30 000 Mahoney David L Stock option (right to buy)
Apr 04, 2024 Sell 5 443 Lyon Joseph Douglas Stock option (right to buy)
Apr 04, 2024 Buy 5 443 Lyon Joseph Douglas Common Stock
Apr 04, 2024 Sell 5 443 Lyon Joseph Douglas Common Stock
Apr 01, 2024 Sell 500 Lyon Joseph Douglas Stock option (right to buy)
Apr 01, 2024 Buy 500 Lyon Joseph Douglas Common Stock
Apr 01, 2024 Sell 500 Lyon Joseph Douglas Common Stock
Apr 01, 2024 Buy 2 200 Swisher Daniel N Jr Common Stock
Apr 01, 2024 Sell 2 200 Swisher Daniel N Jr Common Stock
Apr 01, 2024 Sell 2 200 Swisher Daniel N Jr Stock option (right to buy)
Mar 27, 2024 Buy 25 953 Maduck Sean Common Stock
Mar 27, 2024 Sell 25 953 Maduck Sean Stock option (right to buy)
Mar 27, 2024 Sell 25 953 Maduck Sean Common Stock
Mar 19, 2024 Buy 10 000 Maduck Sean Common Stock
Mar 19, 2024 Sell 10 000 Maduck Sean Stock option (right to buy)
Mar 18, 2024 Sell 17 219 Maduck Sean Stock option (right to buy)
Mar 18, 2024 Buy 17 219 Maduck Sean Common Stock
Mar 18, 2024 Sell 17 219 Maduck Sean Common Stock
Mar 01, 2024 Buy 507 Lyon Joseph Douglas Common Stock
Mar 01, 2024 Buy 507 Lyon Joseph Douglas Common Stock
Mar 01, 2024 Sell 474 Lyon Joseph Douglas Common Stock
Mar 01, 2024 Buy 636 Maduck Sean Common Stock
Mar 01, 2024 Buy 636 Maduck Sean Common Stock
Mar 01, 2024 Sell 505 Maduck Sean Common Stock
Mar 01, 2024 Sell 604 Guyer William Common Stock
Mar 01, 2024 Buy 554 Mokari Atabak Common Stock
Mar 01, 2024 Buy 554 Mokari Atabak Common Stock
Mar 01, 2024 Sell 517 Mokari Atabak Common Stock
Mar 01, 2024 Sell 2 200 Swisher Daniel N Jr Stock option (right to buy)
Mar 01, 2024 Buy 2 200 Swisher Daniel N Jr Common Stock
Mar 01, 2024 Sell 2 200 Swisher Daniel N Jr Common Stock
Mar 01, 2024 Buy 697 Robb Gary Charles Common Stock
Mar 01, 2024 Buy 697 Robb Gary Charles Common Stock
Mar 01, 2024 Sell 656 Robb Gary Charles Common Stock
Feb 16, 2024 Sell 1 000 Lyon Joseph Douglas Stock option (right to buy)
Feb 16, 2024 Buy 1 000 Lyon Joseph Douglas Common Stock
Feb 16, 2024 Sell 1 000 Lyon Joseph Douglas Common Stock
Feb 16, 2024 Sell 14 842 Maduck Sean Stock Option (right to buy)
Feb 16, 2024 Buy 14 842 Maduck Sean Common Stock
Feb 16, 2024 Buy 12 226 Maduck Sean Common Stock
Feb 16, 2024 Sell 27 068 Maduck Sean Common Stock
Feb 16, 2024 Sell 12 226 Maduck Sean Stock Option (right to buy)
Feb 15, 2024 Buy 4 760 Maduck Sean Common Stock
Feb 15, 2024 Sell 4 760 Maduck Sean Common Stock
Feb 15, 2024 Sell 4 760 Maduck Sean Stock option (right to buy)
Feb 09, 2024 Buy 200 000 Maduck Sean Stock option (right to buy)
Feb 09, 2024 Buy 500 000 Belanoff Joseph K Stock option (right to buy)
Feb 09, 2024 Buy 200 000 Guyer William Stock option (right to buy)
Feb 09, 2024 Buy 150 000 Lyon Joseph Douglas Stock option (right to buy)
Feb 09, 2024 Buy 200 000 Hunt Hazel Stock option (right to buy)
Feb 09, 2024 Buy 200 000 Mokari Atabak Stock option (right to buy)
Feb 09, 2024 Buy 200 000 Robb Gary Charles Stock option (right to buy)
Feb 01, 2024 Sell 2 200 Swisher Daniel N Jr Stock option (right to buy)
Feb 01, 2024 Buy 2 200 Swisher Daniel N Jr Common Stock
Feb 01, 2024 Sell 2 200 Swisher Daniel N Jr Common Stock
Jan 08, 2024 Buy 50 000 Hunt Hazel Common Stock
Jan 08, 2024 Sell 29 792 Hunt Hazel Common Stock
Jan 08, 2024 Sell 50 000 Hunt Hazel Stock Option (right to buy)
Jan 02, 2024 Sell 2 200 Swisher Daniel N Jr Stock option (right to buy)
Jan 02, 2024 Buy 2 200 Swisher Daniel N Jr Common Stock
Jan 02, 2024 Sell 2 200 Swisher Daniel N Jr Common Stock
Dec 31, 2023 Sell 0 Baker G Leonard Jr Common Stock
Dec 31, 2023 Buy 0 Baker G Leonard Jr Common Stock
Dec 31, 2023 Buy 0 Robb Gary Charles Common Stock
Dec 31, 2023 Buy 0 Robb Gary Charles Common Stock
Dec 22, 2023 Sell 10 000 Guyer William Stock Option (right to buy)
Dec 22, 2023 Buy 10 000 Guyer William Common Stock
Dec 22, 2023 Sell 10 000 Guyer William Common Stock
Dec 15, 2023 Sell 750 Robb Gary Charles Common Stock
Dec 13, 2023 Sell 1 000 Robb Gary Charles Common Stock
Dec 08, 2023 Buy 639 Robb Gary Charles Common Stock
Dec 06, 2023 Sell 6 212 Robb Gary Charles Common Stock
Dec 05, 2023 Sell 1 381 Robb Gary Charles Common Stock
Dec 04, 2023 Sell 15 000 Robb Gary Charles Stock option (right to buy)
Dec 04, 2023 Buy 15 000 Robb Gary Charles Common Stock
Dec 04, 2023 Sell 8 788 Robb Gary Charles Common Stock
Dec 04, 2023 Buy 2 432 Lyon Joseph Douglas Common Stock
Dec 04, 2023 Sell 2 432 Lyon Joseph Douglas Common Stock
Dec 01, 2023 Sell 2 200 Swisher Daniel N Jr Stock option (right to buy)
Dec 01, 2023 Buy 2 200 Swisher Daniel N Jr Common Stock
Dec 01, 2023 Sell 2 200 Swisher Daniel N Jr Common Stock
Dec 01, 2023 Sell 5 000 Lyon Joseph Douglas Stock option (right to buy)
Dec 01, 2023 Buy 2 568 Lyon Joseph Douglas Common Stock
Dec 01, 2023 Buy 460 Lyon Joseph Douglas Common Stock
Dec 01, 2023 Buy 460 Lyon Joseph Douglas Common Stock
Dec 01, 2023 Buy 14 991 Maduck Sean Common Stock
Dec 01, 2023 Buy 10 009 Maduck Sean Common Stock
Dec 01, 2023 Buy 582 Maduck Sean Common Stock
Dec 01, 2023 Buy 582 Maduck Sean Common Stock
Dec 01, 2023 Sell 25 000 Maduck Sean Common Stock
Dec 01, 2023 Sell 14 991 Maduck Sean Stock option (right to buy)
Dec 01, 2023 Sell 10 009 Maduck Sean Stock option (right to buy)
Dec 01, 2023 Buy 609 Guyer William Common Stock
Dec 01, 2023 Buy 609 Guyer William Common Stock
Dec 01, 2023 Buy 508 Mokari Atabak Common Stock
Dec 01, 2023 Buy 508 Mokari Atabak Common Stock
INSIDER POWER
61.032
Last 100 transactions
Buy: 1 925 494 | Sell: 448 997 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 61.032.

In total, the insiders bought 1 925 494 and sold 448 997 CORT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT